Exact Mass: 371.1288132000001

Exact Mass Matches: 371.1288132000001

Found 136 metabolites which its exact mass value is equals to given mass value 371.1288132000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Methyl-14-O-demethylepiporphyroxine

17-methoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14,16,18-hexaene-11,16-diol

C20H21NO6 (371.13688060000004)

N-Methyl-14-O-demethylepiporphyroxine is an alkaloid from Papaver somniferum (opium poppy

4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside

4-(2-amino-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-4-oxobutanoic acid

C16H21NO9 (371.1216256)

4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside, also known as 4-AHPh-oba-glu, is classified as a member of the Phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside is considered to be slightly soluble (in water) and acidic

2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline

2-(4-((2,5-Difluorophenyl)methoxy)phenoxy)-5-ethoxyaniline

C21H19F2NO3 (371.13329280000005)

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

(3Z)-N,N-Dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-2,3-dihydro-1H-indole-5-sulphonamide

C19H21N3O3S (371.13035560000003)

N-(3-hydroxy-1,2,10-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)formamide

C20H21NO6 (371.13688060000004)

(7S)-6-methoxy-2-methyl-6,8,3,4-tetrahydro-2H-(7rN)-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-6t,8t,7-triol|ledeboridine|Ledebouridin|ledebouridine

C20H21NO6 (371.13688060000004)

Andesine

C20H21NO6 (371.13688060000004)

Chiloenine

C20H21NO6 (371.13688060000004)

2-Demethylcolchicein|2-Desmethylcolchicein|3-Demethyl-colchicein

C20H21NO6 (371.13688060000004)

Cryptopleurospermin|Cryptopleurospermine|[6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-yl]-(3-hydroxy-4-methoxy-phenyl)-ethanedione

C20H21NO6 (371.13688060000004)

SCHEMBL12714883

C17H17N5O5 (371.1229632)

Grossularine 2

C21H17N5O2 (371.1382182)

CHEMBL1668601

C20H21NO6 (371.13688060000004)

NSC180532

C20H21NO6 (371.13688060000004)

5,6-dimethoxy-2-(2,5,6-trimethoxyphenyl)-1h-quinolin-4-one

C20H21NO6 (371.13688060000004)

2-Demethyl-N-deacetyl-N-formylcolchicine|2-Demethyl-N-formyl-N-desacetyl-colchicin

C20H21NO6 (371.13688060000004)

NSC354974

C20H21NO6 (371.13688060000004)

(-)-8-oxo-2,10-dihydroxy-3,9,11-trimethoxyberberine

C20H21NO6 (371.13688060000004)

CHEMBL1668602

C20H21NO6 (371.13688060000004)

C20H21NO6

C20H21NO6 (371.13688060000004)

(-)-(S)-O-acetylevodine

C20H21NO6 (371.13688060000004)

Trigonostemine B

C22H17N3O3 (371.12698520000004)

(+)-N-methoxycarbonyl-lindcarpine

C20H21NO6 (371.13688060000004)

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylidene)-1H-indole-5-sulfonamide

C19H21N3O3S (371.13035560000003)

C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide

NCGC00385471-01_C20H21NO6_6-Methoxy-2-methyl-3,4,6,8-tetrahydro-2H-spiro[indeno[4,5-d][1,3]dioxole-7,1-isoquinoline]-7,8-diol 2-oxide

C20H21NO6 (371.13688060000004)

Lycorine-diacetate

C20H21NO6 (371.13688060000004)

[Raw Data] CBA62_Lycorine-2Ac_pos_50eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_40eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_30eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_20eV.txt [Raw Data] CBA62_Lycorine-2Ac_pos_10eV.txt

Duguetine N-oxide

C20H21NO6 (371.13688060000004)

Duguetine ??-N-oxide

C20H21NO6 (371.13688060000004)

SU 6656

2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide

C19H21N3O3S (371.13035560000003)

SU6656 is a Src family kinases inhibitor with IC50s of 280, 20, 130, 170 nM for Src, Yes, Lyn, and Fyn, respectively. SU6656 inhibits FAK phosphorylation at Y576/577, Y925, Y861 sites. SU6656 also inhibits p-AKT.

Alkaloid a4

17-methoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14,16,18-hexaene-11,16-diol

C20H21NO6 (371.13688060000004)

chelidonine monohydrate*

C20H21NO6 (371.13688060000004)

ONO-RS-082

C21H22ClNO3 (371.1288132000001)

ONO-RS-082 is an inhibitor of phospholipase A (PLA)[1]. ONO-RS-082 inhibits PLA2 with the IC50 of 1.0 μM, but does not inhibit PLC even at 100 μM[2].

Fmoc-D-Met-OH

C20H21NO4S (371.1191226000001)

Fmoc-Met-OH

C20H21NO4S (371.1191226000001)

Z-Glu-OBzl

C20H21NO6 (371.13688060000004)

Z-Glu(OBzl)-OH

C20H21NO6 (371.13688060000004)

n6-benzoyl-8-hydroxy-2-deoxyadenosine

C17H17N5O5 (371.1229632)

N-Cbz-D-glutamic acid α-benzyl ester

C20H21NO6 (371.13688060000004)

N6-Benzoyladenosine

C17H17N5O5 (371.1229632)

5-O-BENZOYL-3-AZIDO-3-DEOXYTHYMIDINE

C17H17N5O5 (371.1229632)

SEA-0400

2-(4-((2,5-Difluorobenzyl)oxy)phenoxy)-5-ethoxyaniline

C21H19F2NO3 (371.13329280000005)

Z-D-Glu(OBzl)-OH

C20H21NO6 (371.13688060000004)

Fmoc-cys(et)-oh

C20H21NO4S (371.1191226000001)

GSK 2801

C20H21NO4S (371.1191226000001)

2-[(2-Acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl benzoate

C17H17N5O5 (371.1229632)

1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-

C19H18FN3O4 (371.12812800000006)

SU6656

(3z)-N,N-Dimethyl-2-Oxo-3-(4,5,6,7-Tetrahydro-1h-Indol-2-Ylmethylidene)-2,3-Dihydro-1h-Indole-5-Sulfonamide

C19H21N3O3S (371.13035560000003)

[5-Amino-1-(4-fluorophenyl)-1H-pyrazol-4-YL](3-{[(2R)-2,3-dihydroxypropyl]oxy}phenyl)methanone

C19H18FN3O4 (371.12812800000006)

1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid

C20H21NO6 (371.13688060000004)

N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide

C19H21N3O3S (371.13035560000003)

(R)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.13035560000003)

(S)-N-(3-Indol-1-YL-2-methyl-propyl)-4-sulfamoyl-benzamide

C19H21N3O3S (371.13035560000003)

N-[2-(1H-Indol-5-YL)-butyl]-4-sulfamoyl-benzamide

C19H21N3O3S (371.13035560000003)

(+)-N-(methoxycarbonyl)-N-norboldine

C20H21NO6 (371.13688060000004)

An aporphine alkaloid that is laurolistine with a N-methoxycarbonyl group. Isolated from the aerial parts of Litsea cubeba, it exhibits antimicrobial activities.

4-hydroxy-1-(3-methylbutyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-oxo-1,2-dihydroquinoline-3-carboxamide

C19H21N3O3S (371.13035560000003)

5-(2,3-Dihydroindol-1-ylsulfonyl)-1,3-diethyl-2-benzimidazolone

C19H21N3O3S (371.13035560000003)

[4-[[4-(Methylthio)phenyl]methyl]-1-piperazinyl]-(4-nitrophenyl)methanone

C19H21N3O3S (371.13035560000003)

3-Methyl-1-phenyl-5-thieno[2,3-c]pyrazolecarboxylic acid [2-(butylamino)-2-oxoethyl] ester

C19H21N3O3S (371.13035560000003)

5-(dimethylamino)-N-[4-(hydroxyamino)benzyl]naphthalene-1-sulfonamide

C19H21N3O3S (371.13035560000003)

1,2-Diacetoxylycorine

C20H21NO6 (371.13688060000004)

2-Amino-3-[(3-heptanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C13H26NO9P (371.13451160000005)

(11S,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C20H21NO6 (371.13688060000004)

(11R,12S,13S)-16,17-dimethoxy-11-methyl-11-oxido-3,5-dioxa-11-azoniapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaen-13-ol

C20H21NO6 (371.13688060000004)

N-Methyl-14-O-demethylepiporphyroxine

C20H21NO6 (371.13688060000004)

4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-glucoside

C16H21NO9 (371.1216256)

N,N-dimethyl-2-oxo-3-(4,5,6,7-tetrahydro-1H-indol-2-ylmethylene)indoline-5-sulfonamide

C19H21N3O3S (371.13035560000003)

LPC 5:1;O2

C13H26NO9P (371.13451160000005)

LPE 8:1;O2

C13H26NO9P (371.13451160000005)

FITM

C18H18FN5OS (371.12160300000005)

FITM is a negative allosteric modulator of mGlu1 receptor with a Ki of 2.5 nM.

VUF-5574

C21H17N5O2 (371.1382182)

VUF-5574 is a selective antagonist of adenosine A3 receptor with a Ki of 4.03 nM for the recombinant human receptor[1].

(1r)-11,17-dimethoxy-6,8,12-trioxa-22-azapentacyclo[11.9.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁹]docosa-2(10),3,5(9),14(19),15,17-hexaen-16-ol

C20H21NO6 (371.13688060000004)

n-{5-hydroxy-3,4,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10-yl}carboximidic acid

C20H21NO6 (371.13688060000004)

13-hydroxy-15,16-dimethoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaen-11-ium-11-olate

C20H21NO6 (371.13688060000004)

n-[(10s)-4-hydroxy-3,5,14-trimethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]carboximidic acid

C20H21NO6 (371.13688060000004)

n-[(10s,12r,16s)-5-hydroxy-3,4,14-trimethoxy-13-oxotetracyclo[9.5.0.0²,⁷.0¹²,¹⁶]hexadeca-1(11),2,4,6,14-pentaen-10-yl]carboximidic acid

C20H21NO6 (371.13688060000004)

(2s)-4,9-dihydroxy-2-(2-hydroxypropan-2-yl)-11-methoxy-10-methyl-2h,3h-furo[3,2-b]acridin-5-one

C20H21NO6 (371.13688060000004)

(2s)-n-{6-[(r)-(acetyloxy)(phenyl)methyl]-4-oxopyran-3-carbonyl}-2-methylbutanimidic acid

C20H21NO6 (371.13688060000004)

(2e)-4-({4,8-dimethoxyfuro[2,3-b]quinolin-7-yl}oxy)-2-methylbut-2-en-1-yl acetate

C20H21NO6 (371.13688060000004)

6-methoxy-3-{7-methoxy-9h-pyrido[3,4-b]indole-1-carbonyl}-1h-indole

C22H17N3O3 (371.12698520000004)

16-oxodelavaine

C20H21NO6 (371.13688060000004)

{"Ingredient_id": "HBIN001942","Ingredient_name": "16-oxodelavaine","Alias": "NA","Ingredient_formula": "C20H21NO6","Ingredient_Smile": "CN1C2CC3=CC4=C(C=C3C5(C2C(=C(C(=O)C5)OC)OC)CC1=O)OCO4","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16299","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}